Stakeholder, public feedback to help shape potential enhancements to the Overall Star Ratings on Hospital Compare in 2021
Today, the Centers for Medicare & Medicaid Services sent a letter to companies that provide Medicare prescription drug coverage in Part D explaining that so-called “gag clauses” are unacceptable, as part of the Administration-wide “American Patients First” initiative to lower prescription drug costs.
Good afternoon, it’s a pleasure to be with you today. Pharmacists are on the front lines of patient care and have keen insight to the issues that patients face. We appreciate your hard work, and we look forward to working with you on a goal that I’m sure we share – ensuring that all patients can access their medications at an affordable price.
Today, the Centers for Medicare & Medicaid Services released a redesigned version of the Drug Spending Dashboards. For the first time, the dashboards include year-over-year information on drug pricing and highlight which manufactures have been increasing their prices.
Today, the Centers for Medicare & Medicaid Services announced the release of updated information products that provide greater transparency on drug spending in the Medicare and Medicaid programs.
I am honored to work for a President who is unafraid to take bold actions to put American patients first. Americans, especially our seniors, feel the pain from skyrocketing drug prices. In our system, everyone is winning except for the patient.
The Centers for Medicare & Medicaid Services (CMS) issued an interim final rule with comment period (IFC) to increase the adjusted fee schedule rates for certain durable medical equipment (DME) and enteral nutrition furnished in rural and non-contiguous areas of the country not subject to the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program (CBP) from June 1, 2018, through December 31, 2018.